In addition, the cytotoxicity of the optimal formulation of GAN against B16F10 melanoma cells and the antibacterial and TYR inhibitory activity were investigated compared with those of pure GA for cosmetic and pharmaceutical applications. The gene discussed is TYR; the disease is melanoma.